PubRank

Transpulmonary thermodilution: advantages and limits.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 28625165)

Published in Crit Care on June 19, 2017

Authors

Xavier Monnet1,2,3, Jean-Louis Teboul4,5

Author Affiliations

1: Hôpitaux Universitaires Paris-Sud, Hôpital de Bicêtre, Medical Intensive Care Unit, Le Kremlin-Bicêtre, F-94270, France. xavier.monnet@aphp.fr.
2: Université Paris-Sud, Faculté de médecine Paris-Sud, Inserm UMR S_999, Le Kremlin-Bicêtre, F-94270, France. xavier.monnet@aphp.fr.
3: Service de réanimation médicale, Hôpital de Bicêtre, 78, rue du Général Leclerc, F-94270, Le Kremlin-Bicêtre, France. xavier.monnet@aphp.fr.
4: Hôpitaux Universitaires Paris-Sud, Hôpital de Bicêtre, Medical Intensive Care Unit, Le Kremlin-Bicêtre, F-94270, France.
5: Université Paris-Sud, Faculté de médecine Paris-Sud, Inserm UMR S_999, Le Kremlin-Bicêtre, F-94270, France.

Associated clinical trials:

Complications Related to Transpulmonary Thermodilution (COTRADIL) | NCT04319965

Hemodynamic Characteristics of Patients With SARS-CoV-2 (PiCCOVID) | NCT04337983

Articles citing this ↘

The crashing patient: hemodynamic collapse. Curr Opin Crit Care (2017) 0.75

Main limitations of transpulmonary thermodilution: set targets. Crit Care (2017) 0.75

Short-term effects of passive mobilization on the sublingual microcirculation and on the systemic circulation in patients with septic shock. Ann Intensive Care (2017) 0.75